Resultats globals: 10 registres trobats en 0.02 segons.
Articles, 10 registres trobats
Articles 10 registres trobats  
1.
9 p, 601.4 KB Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer : A Systematic Review and Meta-Analysis / Martinez-Zapata, Maria José (Institut d'Investigació Biomèdica Sant Pau) ; Mathioudakis, Alexander G. (University of Manchester) ; Mousa, Shaker A. (Albany College of Pharmacy and Health Sciences) ; Bauersachs, Rupert (University Medical Center) ; Universitat Autònoma de Barcelona
Patients with cancer are at increased risk of recurrent venous thromboembolism (VTE) and bleeding. Thus, long-term treatment with anticoagulants for secondary prevention is challenging. The objective of this review was to evaluate current evidence on the safety and efficacy of tinzaparin compared with other anticoagulants for long-term VTE treatment in patients with cancer. [...]
2018 - 10.1177/1076029617696581
Clinical and Applied Thrombosis/Hemostasis, Vol. 24 Núm. 2 (january 2018) , p. 226-234  
2.
13 p, 423.1 KB Pharmacological cancer treatment and venous thromboembolism risk / Muñoz Martín, A.J. (Hospital General Universitario Gregorio Marañón) ; Ramírez, S.P. (Hospital General Universitario Gregorio Marañón) ; Morán, L.O. (Hospital General Universitario Gregorio Marañón) ; Zamorano, M.R. (Universidad Complutense de Madrid) ; Benéitez, M.C.V. (Universidad Complutense de Madrid) ; Salcedo, I.A. (Hospital General Universitario Gregorio Marañón) ; Escobar, I.G. (Hospital General Universitario de Ciudad Real) ; Soria Fernández, José Manuel (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Risk factors for cancer-associated thrombosis are commonly divided into three categories: patient-, cancer-, and treatment-related factors. Currently, different types of drugs are used in cancer treatment. [...]
2020 - 10.1093/EURHEARTJ/SUAA004
European heart journal supplements, Vol. 22 (2020) , p. C2-C14  
3.
10 p, 839.2 KB Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism : The RIETECAT study / Trujillo-Santos, Javier (Hospital General Universitario Santa Lucía (Cartagena, Múrcia)) ; Farge-Bancel, Dominique (Université de Paris) ; Pedrajas, José María (Hospital Clínico San Carlos (Madrid)) ; Gómez-Cuervo, Covadonga (Hospital 12 de Octubre (Madrid)) ; Ballaz, Aitor (Hospital de Galdakao (Usansolo, Biscaia)) ; Braester, Andrei (Bar-Ilan University) ; Mahé, Isabelle (Hôpital Louis Mourier) ; Villalobos, Aurora (Hospital Regional Universitario de Málaga) ; Porras, José Antonio (Hospital Universitari Joan XXIII de Tarragona) ; Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and a leading cause of morbidity and death. The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin or tinzaparin for the secondary prevention of VTE in adults with active cancer. [...]
2022 - 10.1002/rth2.12736
Research and Practice in Thrombosis and Haemostasis, Vol. 6 (june 2022)  
4.
11 p, 375.1 KB Predictors of use of direct oral anticoagulants in patients with venous thromboembolism : Findings from the Registro Informatizado Enfermedad Tromboembólica registry / Lorenzo, Alicia (Hospital Universitario La Paz (Madrid)) ; Beroiz, Patricia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ortiz, Salvador (Universidad Autónoma Madrid) ; Del Toro, Jorge (Hospital General Universitario Gregorio Marañón) ; Mazzolai, Lucia (Centre Hospitalier Universitaire Vaudois (CHUV)) ; Bura-Riviere, Alessandra (Hôpital de Rangueil) ; Visonà, Adriana (Ospedale Castelfranco Veneto) ; Verhamme, Peter (University of Leuven) ; Di Micco, Pierpaolo (Ospedale Buon Consiglio Fatebenefratelli) ; Camporese, Giuseppe (University Hospital of Padova (Pàdua, Itàlia)) ; Sancho Bueso, Teresa (Hospital Universitario La Paz (Madrid)) ; Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Current guidelines recommend the use of direct oral anticoagulants (DOACs) for patients with venous thromboembolism (VTE). However little is known about the use of DOACs in daily practice. We used the RIETE registry to identify predictors of use of DOACs for initial and/or long-term therapy of VTE based on patient-related factors, institution-related factors or over time. [...]
2022 - 10.3389/fmed.2022.991376
Frontiers in Medicine, Vol. 9 (november 2022)  
5.
18 p, 1.8 MB Women's values and preferences on low-molecular-weight heparin and pregnancy : a mixed-methods systematic review / León-García, Montserrat (Institut d'Investigació Biomèdica Sant Pau) ; Humphries, Brittany (McMaster University (Canadà)) ; Maraboto, Andrea (Mayo Clinic (Estats Units d'Amèrica)) ; Rabassa Bonet, Montserrat (Institut d'Investigació Biomèdica Sant Pau) ; Boehmer, Kasey R. (Mayo Clinic (Estats Units d'Amèrica)) ; Perestelo-Pérez, Lilisbeth (Servicio Canario de la Salud) ; Xie, Feng (McMaster University (Canadà)) ; Pelayo, Irene (Universidad de Alcalá) ; Eckman, Mark (University of Cincinnati School of Medicine (Estats Units d'Amèrica)) ; Bates, Shannon (McMaster University (Canadà)) ; Selva, A (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Venous thromboembolism (VTE) in pregnancy is an important cause of maternal morbidity and mortality. Low-molecular-weight heparin (LMWH) is the cornerstone of prophylaxis and treatment of thrombotic events during pregnancy. [...]
2022 - 10.1186/s12884-022-05042-x
BMC Pregnancy and Childbirth, Vol. 22 (october 2022)  
6.
10 p, 1.1 MB TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism / Canyelles, Marina (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Plaza, Melania (Institut d'Investigació Biomèdica Sant Pau) ; Rotllan, Noemi (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Llobet, Dolors (Institut d'Investigació Biomèdica Sant Pau) ; Julve i Gil, Josep (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Mojal, Sergi (Institut d'Investigació Biomèdica Sant Pau) ; Diaz-Ricart, Maribel (Universitat de Barcelona) ; Soria Fernández, José Manuel (Institut d'Investigació Biomèdica Sant Pau) ; Escolà-Gil, Joan Carles (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Tondo, Mireia (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Blanco Vaca, Francisco (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Souto, Joan Carles (Institut d'Investigació Biomèdica Sant Pau)
Background: The present work evaluates the association between circulating concentrations of Trimethylamine-N-oxide (TMAO), gamma butyrobetaine (γBB), and trimetyllisine (TML) in controls and patients with venous thromboembolism (VTE) with coagulation parameters. [...]
2022 - 10.3390/jcm11051425
Journal of clinical medicine, Vol. 11 (march 2022)  
7.
4 p, 249.0 KB Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism : Lesson from the RIETE Registry / Di Micco, Pierpaolo (Ospedale Buon Consiglio Fatebenefratelli) ; Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Major bleeding is one of the most dangerous complications for patients undergoing anticoagulant treatment for VTE. Several clinical scores have been planned to identify patients at higher risk of bleeding, and most of them take into consideration the number of platelets in particular if lower than normal. [...]
2019 - 10.2147/JBM.S234053
Journal of Blood Medicine, Vol. 10 (december 2019) , p. 453-456  
8.
10 p, 230.8 KB Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism / López Núñez, Juan José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez Andrés, Ricard (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Di Micco, Pierpaolo (Department of Internal Medicine and Emergency Room, Ospedale Buon Consiglio Fatebenefratelli, Naples, Italy) ; Schellong, Sebastian (Department of Medical Clinic, Municipal Hospital of Dresden Friedrichstadt, Dresden, Germany) ; Gómez-Cuervo, Covadonga (Hospital Universitario 12 de Octubre (Madrid)) ; Sahuquillo, Joan Carles (Hospital Municipal de Badalona) ; Ciammaichella, Maurizio (Department of Emergency Internal Medicine, Ospedale St. John, Rome, Italy) ; Morales, Maria del Valle (Hospital del Tajo (Madrid)) ; Bosevski, Marijan (University Cardiology Clinic, Faculty of Medicine, Skopje, Republic of Macedonia) ; Monreal, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Background The efficacy and safety of the direct oral anticoagulants (DOACs) in fragile patients (age ≥ 75 years and/or creatinine clearance levels ≤ 50 mL/min and/or body weight ≤ 50kg) with venous thromboembolism (VTE) has not been evaluated. [...]
2019 - 10.1055/s-0039-1683970
TH Open: Companion Journal to Thrombosis and Haemostasis, Vol. 3 (march 2019) , p. e67-e76  
9.
8 p, 589.1 KB Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry / Riera Mestre, Antoni (Hospital Universitari de Bellvitge) ; Mora-Luján, José María (Hospital Universitari de Bellvitge) ; Trujillo-Santos, Javier (Hospital General Universitario Santa Lucía (Cartagena, Múrcia)) ; Del Toro, Jorge (Hospital General Universitario Gregorio Marañón) ; Nieto, José Antonio (Hospital Virgen de La Luz (Cuenca)) ; Pedrajas, José María (Hospital Clínico San Carlos (Madrid)) ; López-Reyes, Raquel (Hospital Universitari i Politècnic La Fe (València)) ; Soler, Silvia (Fundació Hospital d'Olot i Comarcal de la Garrotxa) ; Ballaz, Aitor (Hospital de Galdakao (Usansolo, Biscaia)) ; Cerdà, Pau (Hospital Universitari de Bellvitge) ; Monreal, Manel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Background: Limited data exist about the clinical presentation, ideal therapy and outcomes of patients with hereditary hemorrhagic telangiectasia (HHT) who develop venous thromboembolism (VTE). Methods: We used the data in the RIETE Registry to assess the clinical characteristics, therapeutic approaches and clinical outcomes during the course of anticoagulant therapy in patients with HHT according to initial presentation as pulmonary embolism (PE) or deep venous thrombosis (DVT). [...]
2019 - 10.1186/s13023-019-1172-8
Orphanet Journal of Rare Diseases, Vol. 14 Núm. 1 (september 2019) , p. 196  
10.
12 p, 950.8 KB Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? / Mahé, Isabelle (Hôpital Louis Mourier (Colombes, França)) ; Sterpu, Raluca (Hôpital Louis Mourier (Colombes, França)) ; Bertoletti, Laurent (Centre Hospitalier Universitaire de Saint-Étienne (França)) ; López-Jiménez, Luciano (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Mellado Joan, Meritxell (Hospital del Mar (Barcelona, Catalunya)) ; Trujillo-Santos, Javier (Complejo Hospitalario Universitario de Cartagena) ; Ballaz, Aitor (Hospital de Galdakao (Usansolo, Biscaia)) ; Hernández Blasco, Luis Manuel (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Marchena, Pablo Javier (Parc Sanitari Sant Joan de Déu) ; Monreal Bosch, Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; RIETE investigators
Current guidelines of antithrombotic therapy suggest early initiation of vitamin K antagonists (VKA) in non-cancer patients with venous thromboembolism (VTE), and long-term therapy with low-molecular weight heparin (LMWH) for those with cancer. [...]
2015 - 10.1371/journal.pone.0128741
PloS one, Vol. 10, No 6 (June 2015) , p. e0128741  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.